Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-894-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 30 March 2018 - 07 May 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 438 (Isolated Chicken Eye Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- 2017
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU method B.48 (Isolated chicken eye test method for identifying occular corrosives and severe irritants)
- Version / remarks:
- 2017
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- (2-hydroxy-1,1-dimethylethyl)ammonium chloride
- EC Number:
- 221-713-5
- EC Name:
- (2-hydroxy-1,1-dimethylethyl)ammonium chloride
- Cas Number:
- 3207-12-3
- Molecular formula:
- C4H11NO.ClH
- IUPAC Name:
- 1-hydroxy-2-methylpropan-2-aminium chloride
- Test material form:
- liquid
1
Test animals / tissue source
- Species:
- chicken
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: poultry slaughterhouse
- Number of animals: 5
- Characteristics of donor animals: 7-8 weeks old
- Storage, temperature and transport conditions of ocular tissue: The intact heads were transported from the slaughterhouse at ambient temperature (typically between 18°C and 25°C) in plastic boxes humidified with tissues moistened with isotonic saline.
- Time interval prior to initiating testing: max. 2 hours
- Indication of any existing defects or lesions in ocular tissue samples: none
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied: 30 µL
VEHICLE
- Amount applied: 30 µL
- Concentration: 0.9 % (w/v) Sodium Chloride solution - Duration of treatment / exposure:
- 10 seconds
- Number of animals or in vitro replicates:
- Three test item treated eyes, three positive control eyes and one negative control eye were used in this study.
- Details on study design:
- SELECTION AND PREPARATION OF ISOLATED EYES:
After confirming that the eyes were undamaged, the eyes were further dissected from the skull, taking care not to damage the cornea. The eyeball was pulled from the orbit by holding the nictitating membrane firmly with surgical forceps, and the eye muscles was cut with a bent, blunt-tipped scissor. All necessary precautions were taken to aviod any corneal damage due to excessive pressure (i.e, compression artifacts). The visible portion of the optic nerve was left attached to the eye when it was removed from the orbit. Immediately after removing the eye from the orbit, the eye was placed on an absorbent pad and the nictitaing membrane and other connective tissue were removed.
EQUILIBRATION AND BASELINE RECORDINGS
Immediately after examination and approval of all eyes, they were incubated for 55 minutes to equilibrate them to the test system prior to dosing. Following the equilibration period, a zero reference measurement was recorded for corneal thickness and opacity to serve as baseline values (i.e., time=0). Additionally, the fluorescein retention score was also recorded at 0 hr as baseline measurment value.
NUMBER OF REPLICATES: 3 replicates per test item and positive control, 1 replicate per negative control
NEGATIVE CONTROL USED: 0.9 % (w/v) Sodium Chloride solution
POSITIVE CONTROL USED: 5 % Benzalkonium chloride (in saline solution; 9 g NaCl/L)
APPLICATION DOSE AND EXPOSURE TIME: 30 µL, 10 sec
OBSERVATION PERIOD: The treated corneas were evaluated prior to treatment and at approximately 30, 75, 120, 180 and 240 minutes after the post-treatment rinse.
REMOVAL OF TEST SUBSTANCE
- Volume and washing procedure after exposure period: The test item, negative control and positive control were applied for 10 seconds and then rinsed from the eye with isotonic saline (approximately 20 mL) at ambient temperature.
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: determined using the area of the cornea that was most densely opacified for scoring
- Damage to epithelium based on fluorescein retention: none
- Swelling: measured with depth measuring device (Pachymeter)
- Macroscopic morphological damage to the surface: none
SCORING SYSTEM:
- Mean corneal swelling (%)
- Mean maximum opacity score
- Mean fluorescein retention score at 30 minutes post-treatment
DECISION CRITERIA: Decision criteria as indicated in the TG was used.
Results and discussion
In vitro
Results
- Irritation parameter:
- in vitro irritation score
- Run / experiment:
- 1-3
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: The overall ICE class was 2xI and 1xII.
Any other information on results incl. tables
TABLE 1. Corneal swelling/Thickness and isolated chicken eye (ICE) Classification
Treatment |
Eye No. and Sw% |
Corneal Thickness in Instrument Units (µm) at t (Minutes) |
ICE Class |
||||||
Selection |
0 |
30 |
75 |
120 |
180 |
240 |
|||
Negative Control |
1 |
285 |
285 |
288 |
286 |
298 |
299 |
299 |
I |
Sw% |
NA |
NA |
1.05 |
0.35 |
4.56 |
4.91 |
4.91 |
||
Positive control |
2 |
302 |
301 |
337 |
466 |
480 |
539 |
562 |
IV |
Sw% |
NA |
NA |
11.96 |
54.82 |
59.47 |
79.07 |
86.71 |
||
3 |
304 |
306 |
336 |
425 |
465 |
545 |
513 |
||
Sw% |
NA |
NA |
9.80 |
38.89 |
51.96 |
78.10 |
67.65 |
||
4 |
291 |
294 |
344 |
481 |
480 |
536 |
538 |
||
Sw% |
NA |
NA |
17.01 |
63.61 |
63.27 |
82.31 |
82.99 |
||
Mean sw% ±SD |
NA |
NA |
12.92 ±3.70 |
52.44 ±12.53 |
58.23 ±5.75 |
79.83 ±2.20 |
79.12 ±10.11 |
||
Test Item |
5 |
296 |
291 |
324 |
312 |
318 |
317 |
320 |
II |
Sw% |
NA |
NA |
11.34 |
7.22 |
9.28 |
8.93 |
9.97 |
||
6 |
276 |
287 |
318 |
300 |
318 |
314 |
311 |
||
Sw% |
NA |
NA |
10.80 |
4.53 |
10.80 |
9.41 |
8.36 |
||
7 |
302 |
301 |
322 |
314 |
302 |
315 |
301 |
||
Sw% |
NA |
NA |
6.98 |
4.32 |
0.33 |
4.65 |
0.00 |
||
|
Mean sw% ±SD |
NA |
NA |
9.71 ±2.38 |
5.36 ±1.62 |
6.80 ±5.66 |
7.66 ±2.62 |
6.11 ±5.35 |
|
Sw%: Corneal Swelling percentage, SD: Standard deviation, t: time.
TABLE 2. Corneal opacity SCORES and isolated chicken eye (ICE) Classification
Treatment |
Eye No. |
Corneal Opacity Scores at t (Minutes) |
ICE Class |
||||||
Selection |
0 |
30 |
75 |
120 |
180 |
240 |
|||
Negative Control |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
I |
Positive Control |
2 |
0 |
0 |
2 |
2 |
3 |
3 |
4 |
IV |
3 |
0 |
0 |
2 |
2 |
3 |
3 |
4 |
||
4 |
0 |
0 |
2 |
2 |
3 |
3 |
4 |
||
Mean |
0 |
0.0 |
2.0 |
2.0 |
3.0 |
3.0 |
4.0 |
||
Test Item |
5 |
0 |
0 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
I |
6 |
0 |
0 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
||
7 |
0 |
0 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
||
Mean |
0 |
0.0 |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
SD: Standard deviation, t: time.
TABLE 3. Fluorescein retention, Morphological effects andisolated chicken eye (ICE) Classification
Treatment |
Eye No. |
Fluorescein retention at t (Minutes) |
Morphological effects |
ICE Class |
||
Selection |
0 |
30 |
||||
Negative Control |
1 |
0 |
0 |
0 |
No morphological effects observed |
I |
Positive Control |
2 |
0 |
0 |
1 |
Loosening of epithelium |
II |
3 |
0 |
0 |
1 |
Loosening of epithelium |
||
4 |
0 |
0 |
1 |
Loosening of epithelium |
||
Mean |
0 |
0.0 |
1.0 |
NA |
||
Test Item |
5 |
0 |
0 |
0.5 |
No morphological effects observed |
I |
6 |
0 |
0 |
0 |
No morphological effects observed |
||
7 |
0 |
0 |
0 |
No morphological effects observed |
||
Mean |
0 |
0.0 |
0.2 |
NA |
SD: Standard deviation, t: time.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on the percentage of corneal swelling, corneal opacity score, fluroscein retention score and mophologial effects obtained under the laboratory testing conditions and on the basis of overall combination of ICE categories obtained for all three end points the test item was identified as UN GHS No Category.
- Executive summary:
The test item was evaluated in the “Isolated Chicken eye test method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage” according to OECD Guideline for the Testing of Chemicals, Section 4, No. 438, adopted on 9th October 2017. Heads of chickens approximately 7 to 8 weeks old and weighing around 1.5 to 2.5 kg were collected at a poultry slaughterhouse. Within 2 hours of killing, enucleated eyes were placed in a susperfusion apparatus at 32±1.5 °C. Before dosing, the eyes were incubated for 55 minutes to equilibrate them to the test system prior to treatment. Following the equilibration period, a zero reference measurement was recorded for corneal thickness and opacity to serve as baseline (i.e., time=0). Additionally, the fluorescein retention score was also recorded at 0 hour as baseline measurement value. Eyes with corneal opacity <0.5 and fluorescein retention score <0.5 were selected. 30 µL of test item and Benzalkonium chloride [5% in saline solution (9 g NaCl/L)] was applied onto the cornea of three eyes for 10 seconds, respectively. Similalry, 30 µL normal saline, 0.9 % w/v was used as negative control and was applied onto the cornea of a eye for 10 seconds. The control and test eyes were examined for corneal thickness and corneal opacity at 0, 30, 75, 120, 180 and 240 min after treatment and results were recorded according to a fixed scoring system. Fluorescein retention by damaged epithelial cells was scored at 30 min post-treatment. Additionally, the eyes treated with negative control, positive control and test item were evaluated for morphological effects. All examinations were carried out with a slit-lamp microscope and Pachymeter.
The in vitro classification for a test item was assessed by reading the UN GHS classification that corresponds to the combination of categories obtained for corneal swelling, corneal opacity and fluorescein retention. For the test item the combination of ICE categories obtained for corneal swelling, corneal opacity, and fluorescein retention was 2 x I and 1 x II (ICE class of I observed in two endpoints and Class II in one endpoint). Based on the percentage of corneal swelling, corneal opacity score, fluroscein retention score and mophologial effects obtained under the laboratory testing conditions and on the basis of overall combination of ICE categories obtained for all three end points the test item was identified as UN GHS No Category. The test is considered acceptable as the concurrent negative control and the positive control were identified as UN GHS Non-Classified and GHS Category 1, respectively.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.